SCHEMBL25899703

SCHEMBL25899703

Cc1ccc(/C(C#N)=C2C(=C(/C#N)c3ccc(C#N)cc3)C/2=C(/C#N)c2ccc(C#N)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.61
CYP2A6 P11509 2/20 0.61
GSK3B P49841 3/20 0.43
CA2 P00918 3/20 0.42
CA1 P00915 2/20 0.42
CA12 O43570 1/20 0.40
CA3 P07451 1/20 0.40
CA6 P23280 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
MAPT P10636 2/20 0.38
GSK3A P49840 1/20 0.37
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
LMNA P02545 2/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22969336 0.90 ALDH1A1 (0.42) ALDH1A1CYP2A6GSK3BMAPTACHE
SCHEMBL22354992 0.90 CA2 (0.50) ALDH1A1CYP2A6GSK3BCA2CA1
SCHEMBL27329500 0.78 CYP2A6 (1.00) ALDH1A1CYP2A6CA2CA1CA12
SCHEMBL46818 0.78
P-Xylene SCHEMBL3926102 0.78 CYP2A6 (1.00) ALDH1A1CYP2A6CA2CA1CA12
SCHEMBL25899702 0.77 CYP1A1 (0.45) ALDH1A1GSK3BCA2MAPTLMNA
SCHEMBL28089251 0.76 CYP2A6 (0.94) ALDH1A1CYP2A6CA2CA1CA12
SCHEMBL507820 0.76 ALDH1A1 (0.67) ALDH1A1CYP2A6GSK3BCA2CA1
SCHEMBL31331813 0.76 ALDH1A1 (0.67) ALDH1A1CYP2A6GSK3BCA2CA1
Terephthalic Acid SCHEMBL27298641 0.74 ALDH1A1 (0.68) ALDH1A1CYP2A6GSK3BCA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230232710-A1 Organic Compound of Formula (I) for Use in Organic Electronic Devices, an Organic Electronic Device Comprising a Compound of Formula (I) and a Display Device Comprising the Organic Electronic Device NOVALED GMBH (DE) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230232710-A1 Organic Compound of Formula (I) for Use in Organic Electronic Devices, an Organic Electronic Device Comprising a Compound of Formula (I) and a Display Device Comprising the Organic Electronic Device AOX1, CYP2C19, CYP2C9 ALDH1A1 58/4885CYP2A6 54/4885GSK3B 3468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.